Skip to content
Open access

A Staged Deep Learning Framework for Endometriosis-Aware Pelvic MRI Analysis Using UT-EndoMRI

Sep 2026 · International Journal of Innovative Science & Technology · 0 citations · 20 references

Abstract

Endometriosis remains challenging to assess on pelvic MRI because lesions are often small, heterogeneous, and poorly distinguished from surrounding anatomy. This study developed a reproducible two-stage framework using the public UT-EndoMRI dataset to investigate whether lesion-aware segmentation can provide informative representations for subject-level endometriosis-aware prediction. In Stage 1, SegResNet, SwinUNETR, and SwinUNETR with lesion-aware refinement were compared for multi-class pelvic MRI segmentation. The refined SwinUNETR achieved the best test macro-Dice of 0.0786 and macro IoU of 0.0447, although ovary and lesion segmentation remained weak. The selected model was subsequently frozen and used to generate segmentation-informed features for Stage 2. A cohort of 121 subjects comprising 110 proxy/inferred positive and 11 proxy negative cases was evaluated using repeated five-fold stratified cross-validation over five repeats with L2-regularized logistic regression. The combined uncalibrated feature model achieved a balanced accuracy of 0.8215 ± 0.0798, MCC of 0.3953 ± 0.1172, and AUC of 0.8597 ± 0.0578. Subject-aggregated estimates were balanced accuracy 0.8364 (95% CI: 0.7955–0.8818), MCC 0.3968 (95% CI: 0.3407–0.4765), and AUC 0.8620 (95% CI: 0.7793–0.9306; permutation p = 0.00498). Isotonic calibration improved probability quality, reducing the Brier score to 0.0653 and ECE to 0.0380. These findings indicate that segmentation-informed representations can support internal subject-level prediction beyond coarse MRI summaries; however, the small negative class, weak lesion segmentation, proxy/inferred labels, possible target–predictor dependency, and absence of external validation preclude claims of clinical diagnostic validity.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.